Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O T Wiebenga

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neurology|November 30, 2011
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosisO T Wiebenga, H E Hulst, E-J Kooi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 19, 2013
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosisM M Schoonheim, Jjg Geurts, O T Wiebenga, et al.
AJNR. American Journal of Neuroradiology|March 12, 2016
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple SclerosisO T Wiebenga, M M Schoonheim, H E Hulst, et al.
AJNR. American Journal of Neuroradiology|March 7, 2015
Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosisO T Wiebenga, A M Klauser, M M Schoonheim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neurology|November 30, 2011
Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosisO T Wiebenga, H E Hulst, E-J Kooi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 19, 2013
Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosisM M Schoonheim, Jjg Geurts, O T Wiebenga, et al.
AJNR. American Journal of Neuroradiology|March 12, 2016
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple SclerosisO T Wiebenga, M M Schoonheim, H E Hulst, et al.
AJNR. American Journal of Neuroradiology|March 7, 2015
Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosisO T Wiebenga, A M Klauser, M M Schoonheim, et al.
Pageof 1